Agus MS, Swain JF, Larson CL, Eckert EA & Ludwig DS
(2000) Dietary composition and physiologic adaptations to energy restriction. Am J Clin Nutr 71, 901–907.
Andersen P, Seljeflot I, Abdelnoor M, Arnesen H, Dale PO, Lovik A & Birkeland K
(1995) Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome. Metabolism 44, 611–616.
Appel LJ, Moore TJ & Obarzanek E
(1997) for the DASH Collaborative Research Group A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336, 1117–1124.
Ard JD, Grambow SC, Liu D, Slentz CA, Kraus WE & Svetkey LP
(2004) The effect of the PREMIER interventions on insulin sensitivity. Diabetes Care 27, 340–347.
Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E & Hill JO
(2000) The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br J Nutr 83, Suppl. 1, S25–S32.
Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF
(2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85, 2434–2438.
Atimo WU, El-Mahdi E & Hardiman P
(2003) Familial associations in women with polycystic ovary syndrome. Fertil Steril 80, 143–145.
Augustin LS, Dal Maso L, La Vecchia C, Parpinel M, Negri E, Vaccarella S, Kendall CW, Jenkins DJ & Francesch S
(2001) Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study. Annals of Oncology 12, 1533–1538.
Augustin LS, Gallus S, Bosetti C, Levi F, Negri E, Franceschi S, Dal Maso L, Jenkins DJ, Kendall CW & La Vecchia C
(2003) Glycemic index and glycemic load in endometrial cancer. Int J Cancer 105, 404–407.
Baba NH, Sawaya S, Torbay N, Habbal Z, Azar S & Hashim SA
(1999) High protein vs high carbohydrate hypoenergetic diet for the treatment of obese hyperinsulinemic subjects. Int J Obes 23, 1202–1206.
Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G & Kaaks R
(2001) Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomised trial. Cancer Epidemiol Biomark Prev 10, 25–33.
Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G & Abyholm T
(2002) Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 54, 94–98.
Boeing H, Weisgerber UM, Jeckel A, Rose HJ & Kroke A
(2000) Association between glycated hemoglobin and diet and other lifestyle factors in a nondiabetic population: cross-sectional evaluation of data from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition Study. Am J Clin Nutr 71, 1115–1122.
Bouche C, Rizkalla SW, Luo J, Vidal H, Veronese A, Pacher N, Fouquet C, Lang V & Slama G
(2002) Five week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care 25, 822–828.
Brand-Miller J, Hayne S, Petocz P & Colagiuri S
(2003) Low-glycemic index diets in the management of diabetes: a meta-analysis of randomised controlled trials. Diabetes Care 26, 2261–2267.
Bray G & Popkin B
(1998) Dietary fat intake does affect obesity!. Am J Clin Nutr 68, 1157–1173.
Brynes AE, Edwards MC, Ghatei MA, Dornhorst A, Morgan LM, Bloom SR & Frost GS
(2003) A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. Br J Nutr 89, 207–218.
Byrne CD, Wareham NJ, Brown DC, Clark PM, Cox LJ, Day NE, Palmer CR, Wang TW, Williams DR & Hales CN
(1994) Hypertriglycerideaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia 37, 889–896.
Carlsson M, Westman Y, Almgren P & Groop L
(2000) High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Aterioscler Thromb Vasc Biol 20, 1588–1594.
Chang RJ, Nakamura RM, Judd HL & Kaplan SA
(1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57, 356–359.
Ciaraldi TP, Morales AJ, Hickman MG, Odom-Ford R, Olefsky JM & Yen SS
(1997) Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J Clin Endocrinol Metab 82, 1421–1425.
(1997) Diet, exercise and feto-placental growth. Arch Gynecol Obstet 261, 101–107.
Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X & Norman RJ
(1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10, 2705–2712.
Clark AM, Thornley B, Tomlinson L, Galletley C & Norman RJ
(1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 13, 1502–1505.
Colagiuri S & Brand Miller J
(2002) The ‘carnivore connection’ – evolutionary aspects of insulin resistance. Eur J Clin Nutr 56, Suppl. 1, S30–S35.
Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC & Seizer FE
(1992) Diet and risk of clinical diabetes in women. Am J Clin Nutr 55, 1018–1023.
Collette C, Percheron C, Pares-Herbute N, Michel F, Pham T-C, Brillant L, Descomps B & Monnier L
(2003) Exchanging carbohydrate for monounsaturated fats in energy-restricted diets: effects on metabolic profile and other cardiovascular risk factors. Int J Obes 27, 648–656.
Conway GS, Agrawal R, Betteridge DJ & Jacobs HS
(1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol 37, 119–125.
Coulam CB, Annegers JF & Kranz JS
(1983) Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 71, 253–256.
Crave JC, Fimbel S, Lejeune H, Cugnardey N, Dechaud H & Pugeat M
(1995) Effects of diet and metformin administration on sex hormone-binding globulin, androgens and insulin in hirsute and obese women. J Clin Endocrinol Metab 80, 2057–2062.
Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A & Ragni G
(2003) Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18, 1928–1932.
Dahlgren E, Janson PO, Johansson S, Lapidus L, Lindstedt G & Tengborn L
(1994) Hemostatic and metabolic variables in women with polycystic ovary syndrome. Fertil Steril 61, 455–460.
Dahlgren E, Janson PO, Johansson S, Lapidus L & Oden A
(1992 a) Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71, 599–604.
Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N & Lundberg PA
(1992 b) Women with polycystic ovary syndrome wedge resected in 1956 to 1965, a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57, 505–513.
Dejager S, Pichard C, Giral P, Bruckert E, Federspield MC, Beucler I & Turpin G
(2001) Smaller LDL particle size in women with polycystic ovary syndrome compared to controls. Clin Endocrinol 54, 455–462.
Diabetes Prevention Program Research Group
(2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393–403.
Dumesnil JG, Turgeon J & Tremblay A
(2001) Effect of a low-glycaemic index-low-fat-high protein diet on the atherogenic metabolic risk profile of abdominally obese men. Br J Nutr 86, 557–568.
Dunaif A, Graf M, Mandeli J, Laumas V & Dobrjansky A
(1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia. J Clin Endocrinol Metab 65, 499–507.
Dunaif A, Segal KR, Futterweit W & Dobrjansky A
(1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38, 1165–1174.
Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP & Ludwig DS
(2003) A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med 157, 773–779.
Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK & Imperial J
(1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141–146.
Etling MW, Korsen TJ, Bezemer PD & Schoemaker J
(2001) Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Hum Reprod 16, 556–560.
Fagot-Campagna A, Balkau B, Simon D, Warnet JM, Claude JR, Ducimetiere P & Eschwege E
(1998) High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int J Epidemiol 27, 809–813.
Farnsworth E, Luscombe ND, Noakes M, Wittert G, Argyiou E & Clifton PM
(2003) Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsuilinemic men and women. Am J Clin Nutr 78, 31–39.
Febbraio MA, Keenan J, Angus DJ, Campbell SE & Garnham AP
(2000) Preexercise carbohydrate ingestion, glucose kinetics, and muscle glycogen use: effect of the glycaemic index. J Appl Physiol 89, 1845–1851.
Fenkci V, Fenkci S, Yilmazer M & Serteser M
(2003) Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fetil Steril 80, 123–127.
Feskens EJ & Kromhout D
(1990) Habitual dietary intake and glucose tolerance in euglycemic men: the Zutphen study. Int J Epidemiol 19, 953–959.
Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS & Klein S
(2003) A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 348, 2082–2090.
Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M, Boyle P, Jenkins DJ, La Vecchia C
(2001) Dietary glycemic load and colorectal cancer risk. Ann Oncol 12, 173–178.
(1995) Polycystic ovary syndrome. N Engl J Med 333, 853–861.
Frost G, Leeds AA, Dore CJ, Madeiros S, Brading S & Dornhurst A
(1999) Glycemic index as a determinant of serum HDL-cholesterol concentration. Lancet 353, 1045–1048.
Furberg A & Thune I
(2003) Metabolic abnormalities (hypertension, hyperglycaemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 104, 669–676.
Gambineri A, Pelusi C & Genghini S
(2004) Effect of flutamide and metformin administered alone or in combination in dieting obese women polycystic ovary syndrome. Clin Endocrinol 60, 241–249.
Gambineri A, Pelusi C, Vicennati V, Pagotto U & Pasquali R
(2002) Obesity and the polycystic ovary syndrome. Int J Obesity 26, 883–896.
(1998) High monounsaturated fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67. Suppl. 577S–582S.
Gerhard GT, Ahmann A, Meeuws K, McMurry MP, Duell PB & Connor WE
(2004) Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes. Am J Clin Nutr 80, 668–673.
Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Tracy T & Moore SK
(1999) Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome. Metabolism 48, 1589–1595.
Goodman MT, Wilkens LR, Hankin JN & Kolonel LN
(1997) The association of dietary phytoestrogens with the risk for endometrial cancer. Am J Epidemiol 146, 294–306.
Guzick DS, Wing R, Smith D, Berga SL & Winters SJ
(1994) Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 61, 598–604.
Hardiman P, Pillay OS & Atiomo W
(2003) Polycystic ovary syndrome and endometrial carcinoma. Lancet 361, 1810–1812.
Hays NP, Starling RD, Liu X, Sullivan DH, Trappe TA, Fluckey JD & Evans WJ
(2004) Effects of an ad libitum low-fat, high carbohydrate diet in body fat distribution in older men and women. Arch Int Med 164, 210–217.
Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK & Guzick DS
(2004) A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 82, 421–429.
Holte J, Bergh T, Berne C, Wide L & Lithell H
(1995) Restored insulin sensitivity but persistantly increased early insulin secretion after weight loss in obese women with PCOS. J Clin Endocrinol Metab 80, 2586–2593.
Holte J, Gennarelli G, Wide L, Lithell H & Berne C
(1998) High prevalence of polycystic ovaries and associated clinical, endocrine and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 83, 1143–1150.
Huber-Buchholz MM, Carey DGP & Norman RJ
(1999) Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab 84, 1470–1474.
Jakubowicz DJ & Nestler JE
(1997) 17α-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weight loss. J Clin Endocrinol Metab 82, 556–560.
Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IE, Asp NG & Vessby BO
(1999) Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care 22, 10–18.
Jenkins DJ, Augustin LS, Dal Maso L
(2003) Dietary glycemic index, glycemic load and ovarian cancer risk: a case-control study in Italy. Ann Oncol 14, 78–87.
Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, Jenkins AL & Axelsen M
(2002) Glycemic index: overview of implications in health and disease. Am J Clin Nutr 76, 266S–273S.
Jenkins DJ, Wolever TM, Kalmusky J, Giudici S, Giordano C, Patten R, Wong GS, Bird JN, Hall M & Buckley G
(1987) Low glycemic index diet in hyperlipidemia: use of traditional starchy foods. Am J Clin Nutr 46, 66–71.
Jenkins DJ, Wolever TM, Kalmusky J, Giudici S, Giordano C, Wong GS, Bird JN, Patten R, Hall M & Buckley G
(1985) Low glycemic index carbohydrate foods in the management of hyperlipidemia. Am J Clin Nutr 42, 604–617.
Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL & Goff DV
(1981) Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34, 362–366.
Jialal I, Naiker P, Reddi K, Moddley J & Joubert SM
(1987) Evidence for insulin resistance in non-obese patients with polycystic ovarian disease. J Clin Endocrinol Metab 64, 1066–1072.
Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC & Hu FB
(2004) Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. Am J Clin Nutr 79, 70–75.
Kasim-Karakas SE, Almario RU, Gregory L, Wong R, Todd H & Lasley BL
(2004) Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. J Clin Endocrinol Metab 89, 615–620.
Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ & Franks S
(1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol 36, 105–111.
Kirchengast S & Huber J
(2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16, 1225–1260.
Knockenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR & Azziz R
(1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83, 3078–3082.
Krebs M, Krssak M, Bernroider E, Anderwald C, Brehm A, Meyerspeer M, Nowotny P, Roth E, Waldhausl W & Roden M
(2002) Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51, 599–605.
Kris-Etherton PM, Binkoski AE, Zhao G, Coval SM, Clemmer KF, Hecker KD, Jacques H & Etherton TD
(2002) Dietary fat: assessing the evidence in support of a moderate-fat diet; the benchmark based on lipoprotein metabolism. Proc Nutr Soc 61, 287–298.
Lanzone A, Caruso A, Di Simone N, De Carolis S, Fulghesu AM & Mancuso S
(1995) Polycystic ovary disease. A risk factor for gestational diabetes. J Reprod Med 40, 312–316.
Lariviere F, Chiasson J, Taverroff A & Hoffer L
(1994) Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans. Metabolism 43, 462–467.
Lee DH, Folsom AR, Jacobs DR Jr
(2004) Dietary iron intake and type 2 diabetes incidence in postmenopausal women: the Iowa Women's Health Study. Diabetologia 47, 185–194.
(2003) Polycystic ovary syndrome and cardiovascular disease: a premature association?. Endocrine Rev 24, 302–312.
Legro RS, Kunselman AR, Dodson WC & Dunaif A
(1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Endocrinol Metab 84, 165–169.
Legro RS, Kunselman AR & Dunaif A
(2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111, 607–613.
Lesser KB & Garcia FA
(1997) Association between polycystic ovary syndrome and glucose intolerance during pregnancy. J Matern Fetal Med 6, 303–307.
Liese AD, Roach AK, Sparks KC, Marquart L, D'Agostino RB Jr & Mayer-Davis EJ
(2003) Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr 78, 965–971.
Linn T, Geyer R, Prassek S & Laube H
(1996) Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependant diabetes mellitus. J Clin Endocrinol Metab 81, 3938–3943.
Linn T, Grönemeyer D, Aygen S, Scholz N, Busch M & Bretzel R
(2000) Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia 43, 1257–1265.
Littman AJ, Beresford SA & White E
(2001) The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control 12, 691–702.
Liu S, Willett WC, Mason JE, Hu FB, Rosner B & Colditz G
(2003) Relation between changes in intake of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 78, 920–927.
Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, Hennekens CH & Manson JE
(2000) A prospective study of dietary glycemic load, carbohydrate intake and risk of coronary heart disease in US women. Am J Clin Nutr 71, 1455–1461.
Lord JM, Flight IHK & Norman RJ
(2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br Med J 327, 951–966.
Lovejoy J & DiGirolamo M
(1992) Habitual dietary intake and insulin sensitivity in lean and obese adults. Am J Clin Nutr 55, 1174–1179.
(2000) Dietary glycemic index and obesity. J Nutr 130, 280S–283S.
Ludwig DS, Majzoub JA, AI-Zahrani A, Dallal GE, Blanco I & Roberts SB
(1999 a) High glycemic index foods, overeating, and obesity. Pediatrics 103, E261–E266.
Ludwig DS, Pereira MA, Kroenke CH, Hilner JE, Van Horn L, Slattery ML, Jacobs DR Jr
(1999 b) Dietary fibre, weight gain and cardiovascular risk factors in young adults. J Am Med Assoc 282, 1539–1546.
McCann SE, Freudenheim JL, Marshall JR & Brasure JR
(2000) Diet in the epidemiology of endometrial cancer in Western New York (United States). Cancer Causes Control 11, 965–974.
McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PWF & Jacques PF
(2004) Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 27, 538–546.
(2000) Dietary treatment of thrombogenic disorders related to the metabolic syndrome. Br J Nutr 83, Suppl. 1, S121–S126.
Marshall JA, Bessesen SH & Hamman RF
(1997) High saturated fat and low starch and fibre are associated with hyperinsulinemia in a non-diabetic population – the San Luis Valley Diabetes Study. Diabetologia 40, 430–438.
Marshall JA, Hamman RF & Baxter J
(1991) High-fat, low carbohydrate diet and the etiology of non-insulin dependent diabetes mellitus. The San Luis Diabetes Study. Am J Epidemiol 134, 590–603.
Marshall JA, Hoag S, Shetterley S & Hamman RF
(1994) Dietary fat predicts conversion from impaired glucose tolerance to NIDDM – The San Luis Valley Diabetes Study. Diabetes Care 17, 50–56.
Mather KJ, Kwan F & Corenblum B
(2000) Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 73, 150–156.
Mayer EJ, Newman B, Quesenberry CP Jr & Selby JV
(1993) Usual dietary fat intake and insulin concentrations in women twins. Diabetes Care 16, 1459–1469.
Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Vitolins MZ, Rewers MJ, Haffner SM, Ayad MF, Bergman RN & Karter AJ
(1997) Dietary fat and insulin sensitivity in a triethnic population. The role of obesitas. The Insulin Resistance Atherosclerosis Study (IRAS). Am J Clin Nutr 65, 79–87.
Meyer KA, Kushi LH, Jacobs DR, Slavin J, Sellers TA & Folsom AR
(2000) Carbohydrates, dietary fibre and incident type 2 diabetes in older women. Am J Clin Nutr 71, 921–930.
Montonen R, Knekt Jarvinen R, Aromaa A & Reunanen A
(2003) Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 77, 622–629.
Moran LJ, Noakes M, Clifton PM, Tomlinson L & Norman RJ
(2003) Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 88, 812.
Moran LJ, Noakes M, Clifton PM, Wittert GA, Tomlinson L, Galletly C, Luscombe ND & Norman RJ
(2004) Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 89, 3337–3344.
Norman RJ, Masters L, Milner CR, Wang JX & Davies MJ
(2001) Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 16, 1995–1998.
Öhrvall M, Berglund L, Salminen I, Lithell H, Aro A & Vessby B
(1996) The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men, 19 years follow up. Atherosclerosis 127, 65–71.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY & An ZX
(1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20, 537–544.
Paolisso G, Tataranni PA, Foley FE, Bogardus C, Howard BV & Ravussin E
(1995) A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38, 1213–1217.
Paradisi G, Fulghesu AM, Ferrazzani S, Moretti S, Proto C, Soranna L, Caruso A & Lanzone A
(1998) Endocrino-metabolic features in women with polycystic ovary syndrome during pregnancy. Hum Reprod 13, 542–546.
Parker B, Noakes M, Luscombe N & Clifton P
(2002) Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 25, 425–430.
Parker DR, Weiss ST, Troisi R, Cassano PA, Vokones PS & Landsberg L
(1993) Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations, the normative aging study. Am J Clin Nutr 58, 129–136.
Pasquali R, Antenucci D, Casimirri F, Venturoli S, Paradisi R, Fabbri R, Balestra V, Melchionda N & Barbara L
(1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68, 173–179.
Pasquali R & Casimirri F
(1993) The impact of obesity on hyperandrogensim and polycystic ovary syndrome in premenopausal women. Clin Endocrinol 39, 1–16.
Pasquali R, Casimirri F, Cantobelli S, Labate AM, Venturoli S, Paradisi R & Zannarini L
(1993) Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogensim. Horm Res 39, 179–187.
Pasquali R, Casimirri F, Venturoli S, Antonio M, Morselli L, Reho S, Pezzoli A & Paradisi R
(1994) Body fat distribution has weight-independent effects on clinical, hormonal and metabolic features of women with polycystic ovary syndrome. Metabolism 43, 706–713.
Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M & Morselli-Labate AM
(2000) Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85, 2767–2774.
Pawlak D, Kushner J & Ludwig D
(2004) Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet 364, 778–785.
Pawlak DB, Denyer GS & Brand-Miller JC
(2000) Low post-prandial fat oxidation after a high glycemic index meal leads to increased body fat in chronically fed rats. Obes Res 8, 128S Abstr.
Pereira MA, Jacobs DR, Pins JJ, Raatz SK, Gross MD, Slavin JL & Seaquist ER
(2002) Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 75, 848–855.
Petridou E, Kedikoglou S, Koukoulomatis P, Dessypris N & Tricholpoulous D
(2002) Diet in relation to endometrial cancer risk: a case-control study in Greece. Nutr Cancer 44, 16–22.
Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH & Jacobs HS
(1998) Mortality of women with polycystic ovaries at long-term follow-up. J Clin Epidemiol 51, 581–586.
Pirwany IR, Fleming R, Greer IA, Packard CJ & Sattar N
(2001) Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol 54, 447–453.
Radon PA, McMahon MJ & Meyer WR
(1999) Impaired glucose tolerance in pregnant women with polysystic ovary syndrome. Obstet Gynecol 94, 194–197.
Riccardi G & Rivellese AA
(2000) Dietary treatment of the metabolic syndrome – the optimal diet. Br J Nutr 83, Suppl. 1, S143–S148.
(2000) High-glycemic index foods, hunger, and obesity: is there a connection?. Nutr Rev 58, 163–169.
Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, Richmond W, Johnston DG & Franks S
(1996) Dyslipidaemia is associated with insulin resistance in women with polycystic ovarian syndrome. Clin Endcrinol 44, 277–284.
Rossetti L, Rothman D, DeFronzo R & Shulman G
(1989) Effect of dietary protein on in vivo insulin and liver glycogen repletion. Am J Physiol 257, E212–E219.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
(2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81, 19–25.
(2003) The contribution of vegetarian diets to health and disease: a paradigm shift?. Am J Clin Nutr 78, Suppl.502S–507S.
Sabuncu T, Vural H & Harma M
(2001) Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 34, 401–413.
Saldana TM, Siega-Riz AM & Adair LS
(2004) Effect of macronutrient intake on the development of glucose intolerance during pregnancy. Am J Clin Nutr 79, 479–486.
Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL & Willett WC
(1997 a) Dietary fibre, glycaemic load and risk of NIDDM in men. Diabetes Care 20, 545–550.
Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL & Willett WC
(1997 b) Dietary fibre, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. J Am Med Assoc 277, 472–477.
Salomaa V, Ahola I, Tuomilehto J, Aro A, Pietinen P, Korhonen HJ & Penttila I
(1990) Fatty acid composition of serum cholesterol esters in different degree of glucose intolerance. Metabolism 39, 1285–1291.
Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Williams M, Gracely EJ & Stern L
(2003) A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med 348, 2074–2081.
Sampson M, Kong C, Patel A, Unwin R & Jacobs HS
(1996) Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol 45, 623–629.
Schulze MB, Manson JE, Willett WC & Hu FB
(2003) Processed meat intake and incidence of type 2 diabetes in younger and middle-aged women. Diabetologia 46, 1465–1473.
Skov AR, Toubro S, Ronn B, Holm L & Astrup A
(1999) Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes 23, 528–536.
Slabber M, Barnard HC, Kuyl JM, Dannhauser A & Schall R
(1994) Effects of a low-insulin response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females. Am J Clin Nutr 60, 48–53.
Song Y, Manson JE, Buring JE & Liu S
(2004) A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the Women's Health Study. Diabetes Care 27, 2108–2115.
Spieth LE, Harnish JD, Lenders CM, Raezer LB, Pereira MA, Hangen SJ & Ludwig DS
(2000) A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med 154, 947–951.
Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL & Legro RS
(2004) A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 81, 630–637.
Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams M, Gracely EJ & Samaha FF
(2004) The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Ann Int Med 140, 778–785.
Strowitzki T, Halser B & Demant T
(2002) Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome. Gynecol Endocrinol 16, 45–51.
Swinburn BA, Metcalf PA & Ley SJ
(2001) Long term (5 year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care 24, 619–624.
Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T & Engberg RA
(1998) Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 51, 415–422.
Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K & Kuller L
(1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15, 821–826.
Talbott EO, Zborowski JV, Guzick DS
, et al. (2000) Increased PAI-1 levels in women with polycystic ovary syndrome: Evidence for a specific ‘PCOS’ effect independent of age and BMI. In Programs and Abstracts of the 40th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, p. 13. San Diego, CA: American Heart Association.
Tsunehara CH, Leonetti DL & Fujimoto WY
(1991) Animal fat and cholesterol intake is high in men with IGT progressing to NIDDM. Diabetes 40, Suppl., 427A.
Tuomilehto J, Lindstrom J & Eriksson JG
(2001) Prevention of type 2 diabetes by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 1343–1350.
Van Dam EW, Roelfsema F, Veldhuis JD, Helmerhorst FM, Frolich M, Meinders AE, Krans HM & Pijl H
(2002) Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am J Physiol 282, E865–E872.
(2000) Dietary fat and insulin action in humans. Br J Nutr 83, Suppl. 1, S91–S96.
Vessby B, Aro A, Skarfors E, Berglund L, Salminen I & Lithell H
(1994 a) The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43, 1353–1357.
Vessby B for the Kanwu Study Group
(1999) Effect of dietary fat on insulin sensitivity and insulin secretion. The Kanwu Study. Diabetologia 42, Suppl. 1, A46.
Vessby B, Tengblad S & Lithell H
(1994 b) The insulin sensitivity is related to the fatty acid composition of the serum lipids and the skeletal muscle phospholipids in 70 year old men. Diabetologia 37, 1044–1050.
Wahrenberg H, Ek I, Reynisdottir S, Carlström K, Bergqvist A & Arner P
(1999) Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 84, 2182–2187.
Wang L, Folsom AR, Zheng Z-J, Pankow JS & Eckfeldt JH
(2003) ARIC Study Investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78, 91–98.
Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N & Rojansakul A
(2001) Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Gyneacol Obstet 75, 177–184.
Wijeyarante CN, Nirantharakumar K, Balen AH, Barth JH, Sheriff R & Belchetz PE
(2004) Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol 60, 560–567.
(1995) Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med 98, S27–S32.
Wild RA, Alaupovic P & Parker LJ
(1992) Lipid and apolipoprotein abnormalities in hirsute women I. The association with insulin resistance. Am J Obstet Gynecol 166, 1191–1196.
Wild S, Pierpoint T, McKeigue P & Jacobs HS
(2000) Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 52, 595–600.
(1992) Beneficial effect of a low glycemic index diet in type 2 diabetes. Diabet Med 9, 451–458.
Wolever TM, Jenkins DJ, Vuskan V, Jenkins AL, Wong GS & Josse RG
(1992) Beneficial effect of low-glycemic index diet overweight NIDDM subjects. Diabetes Care 15, 562–564.
Wolever TMS & Mehling C
(2002) Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglyerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. Am J Clin Nutr 77, 612–621.
World Cancer Research Fund
(1997) Food, Nutrition and Cancer: a Global Perspective. Washington, DC: American Institute of Cancer Research.
Wu CL, Nicholas C, Williams C, Took A & Hardy L
(2003) The influence of high-carbohydrate meals with different glycaemic indices on substrate utilization during subsequent exercise. Br J Nutr 90, 1049–1056.
Yang EJ, Kerver JM, Park YK, Kayitsinga J, Allison DB & Song WO
(2003) Carbohydrate intake and biomarkers of glycemic control among US adults: the third National Health and Nutrition Examination Survey (NHANES III). Am J Clin Nutr 77, 1426–1433.
Yildirim B, Sabir N & Kaleli B
(2003) Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril 79, 1358–1364.
Zheng W, Kushi LH, Potter JD, Sellers TA, Doyle TJ, Bostick RM & Folsom AR
(1995) Dietary intake of energy and animal foods and endometrial cancer. Am J Epidemiol 142, 388–394.